Find uplifting stories about heroes, innovations, and solutions
2923 results for "bird flu vaccine"
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
Victoria is launching the world's largest wild bird vaccination program, protecting more than 5,000 little penguins from deadly H5N1 bird flu. Wildlife officers are catching the world's smallest penguins twice to deliver life-saving doses at popular colonies.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
When bird flu reached Australia and New Zealand in 2026, one country was already two years ahead with a plan to save its most endangered species. New Zealand's vaccination program shows how early preparation can protect wildlife facing global threats.
Scientists are testing an mRNA vaccine that could be ready before a bird flu pandemic ever starts. Unlike COVID-19, this time we'd have protection waiting on the shelf.
Britain just launched a groundbreaking 24-week trial to vaccinate turkeys against bird flu, a disease that's cost the government and poultry industry up to £174 million annually. This marks a major shift in strategy that could protect food supplies and prevent devastating flock losses.
A potentially life-saving bird flu vaccine is moving forward in clinical trials, even after the US government canceled hundreds of millions in funding. International partnership keeps pandemic preparedness effort alive with 4,000 volunteers.
Scientists developed a nasal spray that stops H5N1 bird flu in the nose and lungs, outperforming traditional shots in animal tests. The breakthrough could prevent future pandemics by blocking infection where it starts.
Scientists are working late into the night to protect Victoria's iconic little penguin colony with a first-of-its-kind mass vaccination program. The effort comes as bird flu reaches Australian shores, but researchers are fighting back with hope and quick action.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
Teams on an Australian beach are vaccinating thousands of wild penguins against deadly bird flu in a world first program. The tiny birds waddle ashore each night into the arms of scientists racing to protect them before the virus spreads.
South Australia is training 50 volunteer bird watchers to become frontline defenders against bird flu, turning passionate hobbyists into vital disease detectors. The program harnesses citizen scientists who already spend hours observing wildlife to help protect both wild birds and commercial poultry.
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
A new flu vaccine using the same technology that powered COVID shots just proved more effective than traditional options in a 40,000-person study. The breakthrough could reshape how we protect ourselves from seasonal flu.
Researchers worldwide are developing vaccines that could protect against multiple flu strains for years, ending the need for annual shots. Around a dozen candidates are already in clinical trials.
The FDA just approved America's first mRNA flu vaccine for people 50 and older, bringing the same technology that powered COVID vaccines to seasonal flu prevention. The shot could arrive in pharmacies this fall, offering better protection through faster strain matching.
Showing 20 of 2923